- Long-Term Efficacy and Safety of Enlicitide in an Open-Label Extension Study
-
MDP2857
Christie Ballantyne, Baylor Coll Med, Houston, TX; Johnathan Parham, Jodi Carrillo, Puja Banka, Merck & Co., Inc., Rahway, NJ; Alberico L Catapano, Univ of Milan; IRCCS Multimedica, Milano, Italy; Dirk Jacobus Blom, Univ of Cape Town, Cape Town, South Africa; Alberto Cadena, Clínica de la Costa, Barranquilla, Colombia; Norman E Lepor, Natl Heart Inst, Beverly Hills, CA; Kazuhisa Tsukamoto, Teikyo Univ Sch of Med, Tokyo, Japan; Julio E Nuez Llota, Univ Hosp of Valencia, Madrid, Spain; Jean-Claude Tardif, Montreal Heart Inst, Univ de Montréal, Montreal, QC, Canada; Emil Andreas Asprusten, Lipid Clinic, Oslo Univ Hosp, Oslo, Norway; Russell SCOTT, NZ Clinical Res, Christchurch, New Zealand; Weiwei He, Merck & Co., Inc., Rahway, PA; Przem Gorski, Laura Gellis, Merck & Co., Inc., Rahway, NJ; Erik S Stroes, Dept of Vascular Med, Amsterdam Cardiovascular Sciences, Amsterdam UMC, Univ of Amsterdam, Amsterdam, Netherlands; Ann Marie Navar, Dept of Med, Div of Cardiology, Univ of Texas Southwestern Medical Ctr, Dallas, TXGeneric 'disconnected' MessageCommunitiesNavigationSession TypeOnsite Viewing
Enter Note
Go to previous page in this tab
Session


